← Leaderboards
Joel S. Gordon
Signum Biosciences
$1,767,940
Attributed
$1,767,940
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $785.1K · FY2008–10$1M$750K$500K$250K$0
'08
'09
'10
Funding mix
By agency
NIH$1,767,940 · 4
By mechanism
R43$982,841 · 3
R44$785,099 · 1
Top collaborators
No co-investigators on record.
Most similar at Signum Biosciences
Same institution · by research overlap
- Braham Shroot$3,520,255
- Edwardo Eddie Perez$4,933,325
Others in their field
Top investigators on “Topical Application”
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$133,963,145
- Ronald T Mitsuyasu · University Of California Los Angeles$100,512,137
- Gregg H Gilbert · University Of Alabama At Birmingham$66,631,218
- Abhik Das · Research Triangle Institute$58,722,383
- John Morris · Washington University$38,128,685
- Stephen T Higgins · University Of Vermont &St Agric College$30,355,327
Research focus
Topical ApplicationAnti-Inflammatory AgentsAnti-InflammatorySkinScreening ProcedureAnalogLeadBaseSignal PathwayPublic Health RelevanceErythemaIn VivoIn VitroSitePharmacologic SubstanceCutaneousChronicInflammationEar StructureCellsCysteineInflammatoryProgramsGrant
Grant awards (4)
A Novel Class of Therapeutic Agents for the Treatment of Skin Diseases Associated$356,919
R43 · FY2010 · AR · contact PI
A Novel Class of Topical Pleitropic Anti-Acne Therapeutics$327,178
R43 · FY2010 · AR · contact PI
Topical Non-Steroidal Anti-Inflammatories for the Treatment of Rosacea$785,099
R44 · FY2009 · AI · contact PI
A Novel Class of Non Steroidal Anti-Inflammatories$298,744
R43 · FY2008 · AI · contact PI